SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GLGC Gene Logic
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Push who wrote (83)10/2/1999 8:24:00 AM
From: Todd King  Read Replies (1) of 360
 
Steve, two additional questions.

(1) Does the rapidly increasing capability of gene-chips to analyse ever-increasing fractions of the human genome pose a credible threat to the READS franchise? If so, how does GLGC intend to respond to the potential decrease in revenue derived from agreements for target discovery?

(2) Is the GeneExpress market viewed as one with sustainable growth, or is there a threat that growth will slow appreciably as the number of subscribers increases? (perhaps a hundred or so potential customers??)

Thanks!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News